• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SPATZ FGIA INC. SPATZ FGIA INC.; GASTRIC BALLOON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SPATZ FGIA INC. SPATZ FGIA INC.; GASTRIC BALLOON Back to Search Results
Model Number A-SP3US-03K
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Abdominal Pain (1685); Dehydration (1807); Nausea (1970); Vomiting (2144)
Event Date 06/25/2023
Event Type  Injury  
Event Description
On (b)(6) 2023 the patient had egd with up adjustment of spazt 3 balloon 250 cc were added for a total volume of 700 cc.On (b)(6) 2023 patient reported moderate heartburn and nausea/vomiting.She had been discharged with omeprazole 40 mg bid for 14 days as per protocol and was told to take gaviscon q4h prn as well as zofran and hyosciamine.On (b)(6) 2023 patient started having muscle cramps including facial muscle cramps.She was instructed to come to receive iv hydration and labs but opted to visit an er center closer to her home and was given iv hydration and pepcid.Ct abd was unremarkable.Potassium level was low, and she was supplemented.The patient was admitted to the hospital for observation labs and imaging.Results not available at this time.
 
Manufacturer Narrative
"the balloon was not returned for examination.A review of the device labeling notes the following: the physician should also advise the patient that early removal of the balloon may be required due to intolerance or due to serious adverse events.It is the responsibility of the physician to advise the patient of the potential need to remove the device in less than 8 months due to balloon deflation.In the event of gastrointestinal intolerance, the physician may advise the patient to decrease balloon volume.It is important to discuss all possible complications and adverse events with the patient.Complications that may result from use of this product include those associated with general endoscopy procedures, those associated with the spatz3 adjustable balloon specifically and those associated with the patient's degree of intolerance to an implanted foreign body.Adverse health consequences resulting from weight loss such as gallstones, dehydration, loss of muscle mass, mood changes, electrolyte abnormalities, menstrual changes and nutritional deficiencies.Acute pancreatitis characterized by nausea, vomiting, abdominal pain, dehydration.The severity can range from mild to severe and may require balloon down adjustment, or removal.This may result in hospitalization, surgery or death in severe cases.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPATZ FGIA INC.
Type of Device
GASTRIC BALLOON
Manufacturer (Section D)
SPATZ FGIA INC.
1801 s perimeter rd, ste 130
fort lauderdale FL 33309
Manufacturer (Section G)
SPATZ FGIA INC.
1801 s perimeter rd, ste 130
fort lauderdale FL 33309
Manufacturer Contact
pnina polishuk
1801 s perimeter rd, ste 130
fort lauderdale, FL 33309
MDR Report Key17387736
MDR Text Key319752452
Report Number3012638928-2023-02856
Device Sequence Number1
Product Code LTI
UDI-Device Identifier860005178803
UDI-Public(01)860005178803(11)2021-11-21(17)2023-11-21(10)211121
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P190012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Physician
Remedial Action Patient Monitoring
Type of Report Initial
Report Date 07/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/21/2023
Device Model NumberA-SP3US-03K
Device Lot Number211121
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/26/2023
Initial Date FDA Received07/25/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/21/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age49 YR
Patient SexFemale
Patient Weight86 KG
Patient EthnicityHispanic
Patient RaceWhite
-
-